• Type: Seminar Series
• Series organiser: Dr Carolina Arancibia (University of Oxford)
• Timing: The third Thursday of the month

Thursday 19 October 2017 (2nd Week, Michaelmas Term)

• 14:30 - Longitudinal analysis of realtime data collection in ulcerative colitis (Alissa Walsh- Simon Travis's group); TiH cell in the gut (Tianqi Leng- Paul Klenerman's group)
  Dr Alissa Walsh (University of Oxford), Tianqi Leng (University of Oxford)

Thursday 16 November 2017 (6th Week, Michaelmas Term)

• 14:30 - Freezing fresh tissue as an alternative to biobank samples- Matthias Friedrich, Powrie lab; A novel innate immune pathway induces antigen presentation to CD8+ T cells- Daniele Corridoni, Simmons lab
  Professor Alison Simmons (University of Oxford), Professor Fiona Powrie (Kennedy Institute of Rheumatlogy)

Thursday 18 January 2018 (1st Week, Hilary Term)

• 14:30 - Bloodletting and the gut microbiome- John Ryan; TBC- Consuelo Anzilotti
  Dr John Ryan (University of Oxford), Dr Consuelo Anzilotti (MRC Human Immunology Unit, University of Oxford)

Thursday 22 February 2018 (6th Week, Hilary Term)

• 14:30 - Analysis of innate-like T cells by chip-cytometry (Joachim Hagel); Raising the profile of your research (Roy Probert)
  Joachim Hagel (University of Oxford), Roy Probert (NHS OUH)

Thursday 17 May 2018 (4th Week, Trinity Term)

• 14:30 - Rory Peters- 'Atopy in IgG4-related disease'; Michael Fitzpatrick- 'TBA'
  Dr Rory Peters, Dr Michael Fitzpatrick

Thursday 21 June 2018 (9th Week, Trinity Term)

• 14:30 - The role of SAMDL9 in immune dysregulation- Smita Patel; PRISE study- Oliver Brain
  Smita Patel (University of Oxford), Oliver Brain (University of Oxford)

Thursday 20 September 2018 (-2nd Week, Michaelmas Term)

• 14:30 - PRISE study: Investigating Cancer Immunotherapy Colitis
  Dr Oliver Brain (University of Oxford)

Thursday 18 October 2018 (2nd Week, Michaelmas Term)

• 14:00 - Innate barrier function as a therapeutic target in IBD
  Dr Zoe Christoforidou (University of Oxford), Dr Sumeet Pandey (University of Oxford)

Thursday 15 November 2018 (6th Week, Michaelmas Term)

• 14:00 - Microbial-host interactions involved in obesity and the response to bariatric surgery
  Dr Alessandra Geremia (University of Oxford ), Dr Carolina Arancibia (University of Oxford), Dr Valentina Greto (University of Oxford)
• 15:00 - Evaluation of stromal compartment activation in therapy-refractory inflammatory bowel disease patients that require surgical intervention
  Dr Matthias Friedrich (University of Oxford)

Thursday 6 December 2018 (9th Week, Michaelmas Term)

• 16:30 - What is CVID? The many requirements for immunoglobulin production in humans
  Professor Bodo Grimbacher (Freiburg, Germany)

Thursday 13 December 2018 (10th Week, Michaelmas Term)

• 16:00 - Standards of gastritis assessment – implications for clinical practice and research
  Dr Jan Bornschein (University of Oxford)

Thursday 17 January 2019 (1st Week, Hilary Term)

• 14:30 - Enteric viral infection in childhood and coeliac disease
  Dr Michael Fitzpatrick
• 15:30 - An investigation into the stability of the adaptive and innate immune compartments within a transplanted small bowel: A pilot study
  Dr Philip Allan (University of Oxford)

Thursday 21 February 2019 (6th Week, Hilary Term)

• 14:30 - IL-23 signalling as a putative novel therapeutic target in human colorectal cancer
  Dr Elizabeth Mann
• 15:00 - Microbiota, intestinal Inflammation and Arthritis - Lessons from a Novel Immunodeficiency.
  Dr Dominik Aschenbrenner ((Uhlig Group) University of Oxford)

Thursday 28 February 2019 (7th Week, Hilary Term)

• 16:00 - Precision Medicine in Inflammatory Bowel Disease - Hype or Hope?
  Professor Jack Satsangi (University of Oxford)

Thursday 21 March 2019 (10th Week, Hilary Term)

• 14:00 - Re-evaluation of human skin dendritic cells using single cell RNAseq; a masquerade ball
  Yi-Ling Chen (Graham Ogg group)
• 15:00 - Illusive benefits and treatment effect heterogeneity in cost-effectiveness analyses
  Dr Joel Smith

Thursday 4 April 2019 (12th Week, Hilary Term)

• 16:30 - Lymphocyte activation gene (LAG)-3 is associated with mucosal inflammation and disease activity in ulcerative colitis
  Dr Stephanie Slevin (University of Oxford)

Thursday 18 April 2019 (-1st Week, Trinity Term)

• 14:30 - Current Clinical Trials in IBD
  Professor Simon Travis (University of Oxford)

Thursday 16 May 2019 (3rd Week, Trinity Term)

• 14:00 - Delineating the pathogenesis of T-cell checkpoint-inhibitor associated colitis
  Dr Sarah Sasson (University of Oxford)

Thursday 6 June 2019 (6th Week, Trinity Term)

• 16:30 - Characterisation of intestinal T cell populations in coeliac disease using single-cell transcriptomic approaches
  Dr Michael Fitzpatrick

Thursday 4 July 2019 (10th Week, Trinity Term)

• 16:30 - When the computer takes over: automated digital endoscopic scoring in IBD
  Dr Peter Bossuyt

Thursday 18 July 2019 (12th Week, Trinity Term)

• 14:30 - Development of invasive and non-invasive markers for the early detection of GI neoplasia and risk stratification
  Dr Elizabeth Bird-Lieberman (University of Oxford)

Thursday 5 September 2019 (19th Week, Trinity Term)

• 16:30 - Probiotics: where did they come from, where are they going?
  Professor Ian Rowland

Thursday 19 September 2019 (21st Week, Trinity Term)

• 14:00 - Single-cell profiling reveals Colonic CD8 Topography in Inflammatory Bowel Disease
  Daniele Corridoni (University of Oxford)

Thursday 7 November 2019 (4th Week, Michaelmas Term)

• 16:30 - Understanding Infection and Pathogenesis from the Epithelial Point of View
  Dr Francesco Boccellato (University of oxford)

Thursday 9 January 2020 (-1st Week, Hilary Term)

• 16:30 - Defining correlates of clinical benefit and autoimmune adverse events secondary to Immune Checkpoint blockade
  Dr Benjamin Fairfax (Molecular Oncology, MRC WIMM)